Editor: What To Know
- “We were able to go from concept to delivery of the devices in two weeks, and that’s been an incredible effort of teamwork with the manufacturer and the hospitals,”.
- Helmsley Charitable Trust reports $4,711,481 in funding will be distributed across five upper-midwestern states to pay for 367 LUCAS mechanical CPR devices to be deployed to hospitals caring for patients during the pandemic and beyond.
- The Helmsley Charitable Trust is partnering with medical facilities in South Dakota, North Dakota, Montana, Wyoming, and Nebraska to ensure the devices are in place before the peak of COVID-19 hits.
Helmsley Charitable Trust reports $4,711,481 in funding will be distributed across five upper-midwestern states to pay for 367 LUCAS mechanical CPR devices to be deployed to hospitals caring for patients during the pandemic and beyond.
“These devices are vital because we don’t want frontline healthcare workers to choose between trying to save a patient or risking exposure to themselves and others to the Coronavirus,” said Walter Panzirer, a trustee for the Helmsley Charitable Trust. “LUCAS has been a proven, effective tool in saving lives during cardiac arrest, and having more of them available during this pandemic will save even more lives, including those of the doctors, nurses and other healthcare workers.”
Research has shown cardiac damage in as many as 1 in 5 COVID-19 patients, leading to heart failure and death even among those who show no signs of respiratory distress. Among patients who recover, many could have long-term effects from such heart damage.
The rise in cardiac complications caused by COVID-19 exposes both patients and healthcare workers to greater risk, as hands-on CPR can be needed for extended periods. Mechanical CPR has been adopted by emergency medical responders and many hospitals around the globe.
The Helmsley Charitable Trust is partnering with medical facilities in South Dakota, North Dakota, Montana, Wyoming, and Nebraska to ensure the devices are in place before the peak of COVID-19 hits. The devices will remain in place after the pandemic as part of the hospitals’ cardiac system of care.
“We were able to go from concept to delivery of the devices in two weeks, and that’s been an incredible effort of teamwork with the manufacturer and the hospitals,” said Panzirer.
